QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine

BACKGROUND: Acetylcholinesterase inhibitors (AChEis) including donepezil, galantamine and rivastigmine are used to treat Alzheimer’s disease (AD). This study aimed to evaluate evidence from the case report literature for an association between these agents and risk of QT interval prolongation and To...

Descripción completa

Detalles Bibliográficos
Autores principales: Malone, Katie, Hancox, Jules C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436781/
https://www.ncbi.nlm.nih.gov/pubmed/32874532
http://dx.doi.org/10.1177/2042098620942416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436781/
https://www.ncbi.nlm.nih.gov/pubmed/32874532
http://dx.doi.org/10.1177/2042098620942416

Ejemplares similares